The National Pharmaceutical Pricing Authority on July 10 notified price control on 50 new drugs and the order will reduce the drug prices by 10-35 percent.
The government's decision to control therapeutic drug prices has unsettled many in the industry. Latest to voice his concern is Aijaz Tobaccowala, managing director, Pfizer India .
Speaking to CNBC-TV18's Archana Shukla Tobaccowala said, "One of the things we always looked for was a certain amount of consultation with the industry before decisions are taken. All I can look forward to is rounds of consultation with the industry before any additional decisions are taken."
Also read: NPPA's unilateral stand-off unhealthy for sector: Biocon
The National Pharmaceutical Pricing Authority on July 10 notified price control on 50 new drugs and the order will reduce the drug prices by 10-35 percent.
Pfizer stock price
On August 08, 2014, Pfizer closed at Rs 1330.30, down Rs 5.35, or 0.4 percent. The 52-week high of the share was Rs 1779.00 and the 52-week low was Rs 1004.10.
The company's trailing 12-month (TTM) EPS was at Rs 73.51 per share as per the quarter ended June 2014. The stock's price-to-earnings (P/E) ratio was 18.1. The latest book value of the company is Rs 641.82 per share. At current value, the price-to-book value of the company is 2.07.
Anda sedang membaca artikel tentang
Hope govt consults us before deciding anything: Pfizer
Dengan url
http://kebugaranhidup.blogspot.com/2014/08/hope-govt-consults-us-before-deciding.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Hope govt consults us before deciding anything: Pfizer
namun jangan lupa untuk meletakkan link
Hope govt consults us before deciding anything: Pfizer
sebagai sumbernya
0 komentar:
Posting Komentar